ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models.

Sara A Flanigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.